| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 3e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.009 |